Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. 1995

F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
Cattedra Malattie Apparato Digerente, Università di Padova, Italy.

OBJECTIVE Little is known about the pathogenesis of liver damage related to hepatitis C virus. The presence of steatosis or increased ferritin levels, and preliminary data on the relevance of iron as a prognostic factor prompted us to ascertain whether hepatitis C virus-related liver damage might be mediated by iron accumulation. METHODS We evaluated the degree of hepatic inflammation and steatosis, serum ferritin, transferrin saturation and iron levels, tissue iron concentrations and iron index, liver glutathione and malondialdehyde in 33 males and 20 females with chronic hepatitis C virus- or hepatitis B virus-related hepatitis (42 + 11). We also considered six patients with both alcohol abuse and hepatitis C virus, four males with chronic alcoholic liver disease and four males with genetic hemochromatosis, giving a total of 67. All diagnoses were histologically confirmed. Patients with cirrhosis were excluded. RESULTS Our data show that: 1. Steatosis is more frequent in hepatitis C virus and hepatitis C virus+alcohol abuse patients; 2. In males, serum ferritin and tissue iron are significantly higher in hepatitis C virus- than in hepatitis B virus-positive patients (p < 0.01 and 0.05); transferrin saturation is higher (p < 0.05) in hepatitis C virus-positive than in hepatitis B virus-positive patients only when males and females are considered together; 3. Serum ferritin and transferrin saturation only correlate with liver iron (r = 0.833 and r = 0.695, respectively, p = 0.00001); tissue iron is significantly higher in hepatitis C virus- than in hepatitis B virus-positive patients (p < 0.05); 4. In patients with chronic hepatitis, serum ferritin is a better marker of liver iron storage than transferrin saturation, both in males and in females; 5. Hepatitis C virus-positive patients have higher malondialdehyde levels and activation of turnover of glutathione, probably in response to free-radical-mediated liver damage. Females have lower liver iron levels but similar trends. CONCLUSIONS These findings suggest that hepatitis C virus-related liver damage is characterized by increased iron storage (possibly induced by the virus) which elicits a free-radical-mediated peroxidation, with consequent steatosis and activation of glutathione turnover.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008054 Lipid Peroxides Peroxides produced in the presence of a free radical by the oxidation of unsaturated fatty acids in the cell in the presence of molecular oxygen. The formation of lipid peroxides results in the destruction of the original lipid leading to the loss of integrity of the membranes. They therefore cause a variety of toxic effects in vivo and their formation is considered a pathological process in biological systems. Their formation can be inhibited by antioxidants, such as vitamin E, structural separation or low oxygen tension. Fatty Acid Hydroperoxide,Lipid Peroxide,Lipoperoxide,Fatty Acid Hydroperoxides,Lipid Hydroperoxide,Lipoperoxides,Acid Hydroperoxide, Fatty,Acid Hydroperoxides, Fatty,Hydroperoxide, Fatty Acid,Hydroperoxide, Lipid,Hydroperoxides, Fatty Acid,Peroxide, Lipid,Peroxides, Lipid
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis

Related Publications

F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
December 1989, Biochemistry international,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
January 1976, Acta medica Academiae Scientiarum Hungaricae,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
January 1995, Pancreas,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
November 1992, Journal of medical virology,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
April 1995, Gastroenterologia y hepatologia,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
March 1989, Archives of biochemistry and biophysics,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
January 1993, Acta gastroenterologica Latinoamericana,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
February 2005, Journal of medical virology,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
January 2005, Klinicheskaia meditsina,
F Farinati, and R Cardin, and N De Maria, and G Della Libera, and C Marafin, and E Lecis, and P Burra, and A Floreani, and A Cecchetto, and R Naccarato
January 2000, Voprosy virusologii,
Copied contents to your clipboard!